Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non Operating Income (2016 - 2025)

Collegium Pharmaceutical (COLL) has 4 years of Other Non Operating Income data on record, last reported at -$4.1 million in Q3 2024.

  • For Q3 2024, Other Non Operating Income changed N/A year-over-year to -$4.1 million; the TTM value through Dec 2024 reached -$11.3 million, up 51.8%, while the annual FY2025 figure was -$16.0 million, 41.18% down from the prior year.
  • Other Non Operating Income reached -$4.1 million in Q3 2024 per COLL's latest filing, up from -$7.2 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $23.5 million in Q1 2023 and bottomed at -$47.0 million in Q2 2023.